ReviewPharmacoEconomics2026
Beyond the States: Developing a Discrete Event Simulation Model Using R.
Review in PharmacoEconomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lowering the Barriers to the Appropriate Use of Individual-Level Simulation for Health Economic Evaluation.PharmacoEconomics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This illustration uses the Scottish Cardiovascular Disease (CVD) Policy Model as a case study to provide a comprehensive, step-by-step guide to building a discrete event simulation (DES) model in R. It is specifically designed for practitioners who are familiar with constructing Markov models in R and wish to transition their theoretical knowledge of DES into practical implementation. The Scottish CVD Policy Model was originally developed as an Excel-based Markov model with a sophisticated structure: a primary Markov model for first events and nested sub-Markov models for subsequent events. Later replicated in R by Xin, Yiqiao et al., the model's source code was made publicly available on GitHub, underscoring its potential as a teaching tool. The intricate structure of this model presents several challenges in health economic modeling, making it an ideal candidate for demonstrating how DES techniques can address such complexities effectively. In this illustration, we deliberately avoid using R packages developed specifically for DES to enhance transparency. Instead, we rely on base R functions, and the tidyverse package for tidy data wrangling. This approach ensures that every step of the DES implementation is clear and reproducible. In addition to covering fundamental topics such as how to simulate a time to event according to an assumed distribution, and continuous discounting, the illustration also provides solutions to more advanced modeling challenges, such as handling piecewise-modeled cost and utility. By discussing both general principles and complex scenarios, this paper equips readers with the practical tools needed to transition from Markov to DES frameworks, enhancing the accuracy and flexibility of health economic evaluations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.